Publications
Awareness and Utilization of Public Physiotherapy Health Care Services to Support People With Multiple Sclerosis: A Health Care Service Audit
S Jasin-Pathiranage, L Grech, C Scroggie, P Sansom
(2024), Vol. 26, pp. 8-12, International Journal of MS Care, Lawrence, KS., C1-1
Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy
D Hertz, C Tofthagen, E Rossi, D Bernasconi, J Lim, M Carlson, K Sheffield, L Nekhlyudov, L Grech, D Von Ah, S Mayo, K Ruddy, A Chan, P Alberti, M Lustberg, M Tanay
(2024), Vol. 32, Supportive Care in Cancer, C1-1
Management of Osteoporosis, Fracture and Falls in People with Multiple Sclerosis: Systematic Review of Guidelines
L Grech, K Laurence, P Ebeling, M Sim, A Zengin
(2024), Vol. 114, pp. 201-209, Calcified Tissue International, C1-1
Medication and bone health in multiple sclerosis: A systematic review and meta-analysis
M Cahyadi, J Mesinovic, S Chim, P Ebeling, A Zengin, L Grech
(2023), Vol. 29, pp. 1331-1353, Journal of managed care & specialty pharmacy, C1
The Disease Influenced Vaccine Acceptance Scale-Six (DIVAS-6): Validation of a Measure to Assess Disease-Related COVID-19 Vaccine Attitudes and Concerns
L Grech, B Loe, D Day, D Freeman, A Kwok, M Nguyen, N Bain, E Segelov
(2023), Vol. 49, pp. 402-411, Behavioral Medicine, Oxford, Eng., C1-1
COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis
L Grech, A Kwok, M Nguyen, A Winkel, E Butler, M Allan, N Bain, E Segelov
(2023), Vol. 11, pp. 1-13, Vaccines, Basel, Switzerland, C1-1
Anticipatory anxiety and participation in cancer screening. A systematic review
B Goodwin, L Anderson, K Collins, S Sanjida, M Riba, G Singh, K Campbell, H Green, S Ishaque, A Kwok, M Opozda, A Pearn, J Shaw, U Sansom-Daly, J Tsirgiotis, M Janda, L Grech
(2023), Vol. 32, pp. 1773-1786, Psycho-Oncology, C1-1
Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model
T Choi, B Chan, L Grech, A Kwok, K Webber, J Wong, M Nguyen, N Bain, D Day, A McCartney, R Hamer, E Segelov
(2023), Vol. 11, pp. 239-239, Vaccines, Switzerland, C1-1
Using CEOS theory to inform the development of behaviour change implementation and maintenance initiatives for people with multiple sclerosis
L Grech, R Borland
(2023), Vol. 42, pp. 7433-7447, Current Psychology, Berlin, Germany, C1-1
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
N Bain, M Nguyen, L Grech, D Day, A McCartney, K Webber, A Kwok, S Harris, H Chau, B Chan, L Nott, N Hamad, A Tognela, C Underhill, B Loe, D Freeman, E Segelov
(2022), Vol. 10, Vaccines, C1-1
The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners
Y Cheung, A Chan, A Charalambous, H Darling, L Eng, L Grech, C van den Hurk, D Kirk, S Mitchell, D Poprawski, E Rammant, I Ramsey, M Fitch, R Chan
(2022), Vol. 30, pp. 1427-1439, Supportive Care in Cancer, Berlin, Germany, C1-1
Smoking habits, awareness and support needs for cessation among people with multiple sclerosis in Australia: findings from an online survey
I Weld-Blundell, L Grech, R Borland, S White, R Das Nair, C Marck
(2022), Vol. 12, pp. 1-10, BMJ Open, London, Eng., C1-1
COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study
M Nguyen, N Bain, L Grech, T Choi, S Harris, H Chau, D Freeman, A Kwok, J Williams, A McCartney, K Webber, D Day, E Segelov
(2022), Vol. 18, pp. 570-577, Asia-Pacific Journal of Clinical Oncology, London, Eng., C1-1
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia
D Day, L Grech, M Nguyen, N Bain, A Kwok, S Harris, H Chau, B Chan, R Blennerhassett, L Nott, N Hamad, A Tognela, D Hoffman, A McCartney, K Webber, J Wong, C Underhill, B Sillars, A Winkel, M Savage, B Loe, D Freeman, E Segelov
(2022), Vol. 10, pp. 1-13, Vaccines, Basel, Switzerland, C1-1
Exercise counselling and referral in cancer care: an international scoping survey of health care practitioners' knowledge, practices, barriers, and facilitators
I Ramsey, A Chan, A Charalambous, Y Cheung, H Darling, L Eng, L Grech, N Hart, D Kirk, S Mitchell, D Poprawski, E Rammant, M Fitch, R Chan
(2022), Vol. 30, pp. 9379-9391, Supportive Care in Cancer, Berlin, Germany, C1-1
Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review
I Weld-Blundell, L Grech, Y Learmonth, C Marck
(2022), Vol. 145, pp. 379-392, Acta Neurologica Scandinavica, C1-1
Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians' experiences
C Marck, A Hunter, E Butler, M Allan, K Edward, A Giles, J Kulkarni, D Rajendran, S Shaw, L Grech
(2022), Vol. 57, pp. 1-8, Multiple Sclerosis and Related Disorders, Amsterdam, The Netherlands, C1-1
Improving the detection and treatment of depression in Australians with multiple sclerosis: A qualitative analysis
A Hunter, C Marck, E Butler, M Allan, K Edward, A Giles, J Kulkarni, D Rajendran, S Shaw, L Grech
(2021), Vol. 56, Multiple Sclerosis and Related Disorders, Amsterdam, The Netherlands, C1-1
Barriers and motivators for tobacco smoking cessation in people with multiple sclerosis
A Hunter, L Grech, R Borland, R das Nair, S White, C Marck
(2021), Vol. 54, pp. 1-9, Multiple Sclerosis and Related Disorders, Amsterdam, The Netherlands, C1-1
Untreated and under-treated depressive symptoms in people with multiple sclerosis in an Australian context: A secondary analysis
L Grech, S Haines, C Marck, R Hester, E Butler
(2021), Vol. 28, pp. 42-47, Collegian, Amsterdam, The Netherlands, C1-1
Relationship Between Interpersonal Depressive Symptoms and Reduced Amygdala Volume in People with Multiple Sclerosis: Considerations for Clinical Practice
S Haines, E Butler, S Stuckey, R Hester, L Grech
(2021), Vol. 23, pp. 178-185, International Journal of MS Care, C1-1
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
S Mayo, M Lustberg, H M. Dhillon, Z Nakamura, D Allen, D Von Ah, M C. Janelsins, A Chan, K Olson, C Tan, Y Toh, J Oh, L Grech, Y Cheung, I Subbiah, D Petranovic, J D’Olimpio, M Gobbo, S Koeppen, C Loprinzi, L Pang, S Shinde, O Ntukidem, K Peters
(2021), Vol. 29, pp. 2821-2840, Supportive Care in Cancer, C1-1
Improving smoking cessation support for people with multiple sclerosis: A qualitative analysis of clinicians' views and current practice
L Grech, A Hunter, R das Nair, R Borland, C Marck
(2021), Vol. 56, pp. 1-7, Multiple Sclerosis and Related Disorders, Amsterdam, The Netherlands, C1-1
Effectiveness of online communication skills training for cancer and palliative care health professionals: A systematic review
M Berg, I Ngune, P Schofield, L Grech, I Juraskova, M Strasser, Z Butt, G Halkett
(2021), Vol. 30, pp. 1405-1419, Psycho-Oncology, C1-1
Objective medication adherence and persistence in people with multiple sclerosis: A systematic review, meta-analysis, and meta-regression
J Mardan, M Hussain, M Allan, L Grech
(2021), Vol. 27, pp. 1273-1295, Journal of Managed Care and Specialty Pharmacy, C1-1
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
D Hertz, D Childs, S Park, S Faithfull, Y Ke, N Ali, S McGlown, A Chan, L Grech, C Loprinzi, K Ruddy, M Lustberg
(2021), Vol. 99, Cancer Treatment Reviews, C1-1
Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression
Joshua Mardan, Mohammad Hussain, Michelle Allan, Lisa Grech
(2021), Vol. 27, pp. 1273-1295, JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, C1-1
Modifiable risk factors for poor health outcomes in multiple sclerosis: The urgent need for research to maximise smoking cessation success
C Marck, R das Nair, L Grech, R Borland, C Constantinescu
(2020), Vol. 26, pp. 266-271, Multiple Sclerosis Journal, C1-1
Neuroprotective benefits of antidepressants in multiple sclerosis: Are we missing the mark?
L Grech, E Butler, S Stuckey, R Hester
(2019), Vol. 31, pp. 289-297, Journal of Neuropsychiatry and Clinical Neurosciences, C1-1
Importance of coping in the relationship between executive function and quality of life in people with multiple sclerosis
L Grech, L Kiropoulos, K Kirby, E Butler, M Paine, R Hester
(2019), Vol. 21, pp. 201-206, International Journal of MS Care, C1-1
Target coping strategies for interventions aimed at maximizing psychosocial adjustment in people with multiple sclerosis
L Grech, L Kiropoulos, K Kirby, E Butler, M Paine, R Hester
(2018), Vol. 20, pp. 109-119, International Journal of MS Care, C1-1
Executive function is an important consideration for coping strategy use in people with multiple sclerosis
L Grech, L Kiropoulos, K Kirby, E Butler, M Paine, R Hester
(2017), Vol. 39, pp. 817-831, Journal of Clinical and Experimental Neuropsychology, C1-1
Coping mediates and moderates the relationship between executive functions and psychological adjustment in multiple sclerosis
L Grech, L Kiropoulos, K Kirby, E Butler, M Paine, R Hester
(2016), Vol. 30, pp. 361-376, Neuropsychology, C1-1
The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis
L Grech, L Kiropoulos, K Kirby, E Butler, M Paine, R Hester
(2015), Vol. 37, pp. 549-562, Journal of Clinical and Experimental Neuropsychology, London, Eng., C1-1
Perceived Barriers Toward Patient-Reported Outcome Implementation in Cancer Care: An International Scoping Survey
Lawson Eng, Raymond Chan, Alexandre Chan, Andreas Charalambous, H Darling, Lisa Grech, Corina van den Hurk, Deborah Kirk, Sandra Mitchell, Dagmara Poprawski, Elke Rammant, Imogen Ramsey, Margaret Fitch, Yin Cheung
(), JCO Oncology Practice, C1
Funded Projects at Deakin
Australian Competitive Grants
A clinician-led feasibility, acceptability and pilot efficacy intervention to improve bone health and muscle strength in people with multiple sclerosis
Dr Lisa Grech, Dr Ayse Zengin, Dr Marc Sim, Ms Michelle Allan, Dr Paul Jansons, Prof Belinda Beck, Prof Peter Ebeling, Timothy O'Maley, Linh Le-Kavanagh, A/Prof Ernest Butler, Prof Allan Kermode, A/Prof David Scott, Dr Nevin John, Dr Jakub Mesinovic, Mr Alan Herschtal
MRFF (NHMRC) - Clinician Researchers Initiative: Applied Research in Health Grant
- 2024: $187,801
Supervisions
No completed student supervisions to report